# Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery

> **NCT03070886** · PHASE2,PHASE3 · COMPLETED · sponsor: **NRG Oncology** · enrollment: 612 (actual)

## Conditions studied

- Stage I Prostate Adenocarcinoma AJCC v7
- Stage II Prostate Adenocarcinoma AJCC v7
- Stage III Prostate Adenocarcinoma AJCC v7

## Interventions

- **DRUG:** Bicalutamide
- **DRUG:** Degarelix
- **DRUG:** Docetaxel
- **RADIATION:** External Beam Radiation Therapy
- **DRUG:** Flutamide
- **DRUG:** Goserelin
- **DRUG:** Goserelin Acetate
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Leuprolide
- **DRUG:** Leuprolide Acetate
- **DRUG:** Nilutamide

## Key facts

- **NCT ID:** NCT03070886
- **Lead sponsor:** NRG Oncology
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-05
- **Primary completion:** 2025-10-31
- **Final completion:** 2025-10-31
- **Target enrollment:** 612 (ACTUAL)
- **Last updated:** 2026-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03070886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03070886, "Antiandrogen Therapy and Radiation Therapy With or Without Docetaxel in Treating Patients With Prostate Cancer That Has Been Removed by Surgery". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03070886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*